BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17561009)

  • 21. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
    Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy.
    Kanda T; Ichikawa S; Sumino H; Sakamaki T; Nakamura T; Tsukui S; Nara M; Kobayashi I; Tamura J
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):179-85. PubMed ID: 11484873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
    Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
    An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone replacement therapy with transdermal estradiol lowers insulin-cortisol and lipoproteins levels in postmenopausal women].
    Basurto L; Saucedo R; Ochoa R; Hernández M; Zárate A
    Ginecol Obstet Mex; 2002 Oct; 70():491-5. PubMed ID: 12557803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
    Duncan AC; Lyall H; Roberts RN; Petrie JR; Perera MJ; Monaghan S; Hart DM; Connell JM; Lumsden MA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
    Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
    Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
    Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal WM; Visser CA; van der Mooren MJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
    Speroff L; Rowan J; Symons J; Genant H; Wilborn W
    JAMA; 1996 Nov; 276(17):1397-403. PubMed ID: 8892714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
    Alexandersen P; Riis BJ; Stakkestad JA; Delmas PD; Christiansen C
    J Clin Endocrinol Metab; 2001 Feb; 86(2):755-60. PubMed ID: 11158042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.
    Spencer CP; Godsland IF; Cooper AJ; Ross D; Whitehead MI; Stevenson JC
    Metabolism; 2000 Jun; 49(6):742-7. PubMed ID: 10877199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
    Farish E; Barnes JF; Rankin M; Hart DM
    Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment.
    Myrup B; Jensen GF; McNair P
    Arch Intern Med; 1992 Nov; 152(11):2265-8. PubMed ID: 1332634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral 17beta-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women.
    Pornel B; Chevallier O; Netelenbos JC
    Menopause; 2002; 9(3):171-8. PubMed ID: 11973440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
    al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
    Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.